AIM: To assess the prognostic significance of imaging findings used in magnetic resonance imaging (MRI) staging of @entity2622 by correlation with survival after radiotherapy. MATERIALS AND METHODS: MRI examinations of 99 @entity2622 @entity1 were reviewed. @entity5 involvement of pelvic structures was assessed. Lymph node sites, short axis diameters and signal characteristics were recorded. MRI staging was compared with clinical [International Federation of Gynaecology and Obstetrics (FIGO)] staging. Univariate analysis was performed for MRI stage, clinical stage, nodal status and pelvic structure involvement against @entity66 ( @entity66 ) and disease-free survival (DFS). RESULTS: MRI staging correlated with @entity66 (p=0.006) and DFS (p=0.007) but clinical staging did not. Pelvic nodes > or = 10 mm and juxtaregional or distant nodes > or = 8 mm short axis were most strongly associated with survival (p=0.014, p=0.011 and p=0.001, respectively, for association with @entity66 ). @entity5 involvement of pelvic bowel loops, pelvic sidewall and bladder mucosa were significantly associated with poor @entity66 and DFS (p<0.05). @entity5 dimensions and bladder muscle involvement alone were not associated with poor survival. CONCLUSION: MRI staging is a better predictor of survival than clinical staging in @entity1 receiving radiotherapy for @entity2622 . MRI assessment of lymph node enlargement and @entity5 involvement of pelvic structures gives valuable prognostic information.

Staging of advanced XXXX using MRI-predictors of outcome after radical radiotherapy.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2622 :: ('MESH:D002583', 'Disease') :: ['cervical carcinoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['Tumour', 'tumour'] @entity66 :: ('MESH:D004194', 'Disease') :: ['disease-specific', 'DSS']
@entity2622 :: (MESH:D002583,Disease) :: ['cervical carcinoma']
